158 related articles for article (PubMed ID: 28812106)
1. [Costs associated with multiresistant bacteria in neurorehabilitation].
Roukens R; Lauster F; Bara M; Eifert B; Willemsen D; Randall T; Herzog J; Wendt C; Schmidt-Wilcke T; Knecht S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Oct; 60(10):1075-1082. PubMed ID: 28812106
[TBL] [Abstract][Full Text] [Related]
2. [Incentives of German Rehabilitation Centers to Implement Screening Strategies for the Prevention of Methicillin-resistant Staphylococcus aureus (MRSA) Transmissions and Infections].
Claus F; Ried W
Rehabilitation (Stuttg); 2015 Jun; 54(3):198-204. PubMed ID: 26091495
[TBL] [Abstract][Full Text] [Related]
3. [On the economic burden of MRSA in Germany].
Claus F; Sachse A; Ried W
Gesundheitswesen; 2014 Dec; 76(12):800-6. PubMed ID: 25372655
[TBL] [Abstract][Full Text] [Related]
4. [Parkinsonian Syndromes: Direct Costs of Inpatient Neurological Rehabilitation].
Bujan B; Müller M
Rehabilitation (Stuttg); 2016 Feb; 55(1):54-8. PubMed ID: 26882139
[TBL] [Abstract][Full Text] [Related]
5. Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects.
Wassenberg MW; Kluytmans JA; Box AT; Bosboom RW; Buiting AG; van Elzakker EP; Melchers WJ; van Rijen MM; Thijsen SF; Troelstra A; Vandenbroucke-Grauls CM; Visser CE; Voss A; Wolffs PF; Wulf MW; van Zwet AA; de Wit GA; Bonten MJ
Clin Microbiol Infect; 2010 Dec; 16(12):1754-61. PubMed ID: 20219077
[TBL] [Abstract][Full Text] [Related]
6. [The MRSA patient in technical orthopaedics and rehabilitation. Part 2: Hygiene management].
Hornberg C; Schäfer TR; Koller A; Wetz HH
Orthopade; 2003 Mar; 32(3):218-24. PubMed ID: 12647043
[TBL] [Abstract][Full Text] [Related]
7. Evidence for cost reduction based on pre-admission MRSA screening in general surgery.
Diller R; Sonntag AK; Mellmann A; Grevener K; Senninger N; Kipp F; Friedrich AW
Int J Hyg Environ Health; 2008 Mar; 211(1-2):205-12. PubMed ID: 17692566
[TBL] [Abstract][Full Text] [Related]
8. [Hospital disinfection challenges due to multiresistant pathogens in surgery].
Exner D; Kalff JC; Engelhart S; Exner M
Zentralbl Chir; 2015 Oct; 140 Suppl 1():S57-72. PubMed ID: 26359807
[TBL] [Abstract][Full Text] [Related]
9. Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment.
Wernitz MH; Keck S; Swidsinski S; Schulz S; Veit SK
Clin Microbiol Infect; 2005 Jun; 11(6):466-71. PubMed ID: 15882196
[TBL] [Abstract][Full Text] [Related]
10. [Methicillin-resistant Staphylococcus aureus (MRSA) in medical rehabilitation. Draft of a model hygiene plan].
Hergenröder H; Mielke M; Höller C; Herr C
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1453-64. PubMed ID: 23114445
[TBL] [Abstract][Full Text] [Related]
11. [Multidrug-Resistant Organisms (MDRO) in Rehabilitation Clinics in the Rhine-Main District, Germany, 2014: Risk Analysis and Hygiene Procedures].
Heudorf U; Färber D; Mischler D; Schade M; Zinn C; Nillius D; Herrmann M
Rehabilitation (Stuttg); 2015 Dec; 54(6):375-81. PubMed ID: 26676735
[TBL] [Abstract][Full Text] [Related]
12. Review of a two-year methicillin-resistant Staphylococcus aureus screening program and cost-effectiveness analysis in Singapore.
Win MK; Soliman TA; Lee LK; Wong CS; Chow A; Ang B; Roman CL; Leo YS
BMC Infect Dis; 2015 Sep; 15():391. PubMed ID: 26419926
[TBL] [Abstract][Full Text] [Related]
13. [Infections caused by multiresistant bacteria].
Zahar JR; Ferroni A
Rev Prat; 2006 Sep; 56(13):1397-404. PubMed ID: 17002063
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital.
Eveillard M; Eb F; Tramier B; Schmit JL; Lescure FX; Biendo M; Canarelli B; Daoudi F; Laurans G; Rousseau F; Thomas D
J Hosp Infect; 2001 Feb; 47(2):116-24. PubMed ID: 11170775
[TBL] [Abstract][Full Text] [Related]
15. Costs of an outbreak of meticillin-resistant Staphylococcus aureus.
Kanerva M; Blom M; Tuominen U; Kolho E; Anttila VJ; Vaara M; Virolainen-Julkunen A; Lyytikäinen O
J Hosp Infect; 2007 May; 66(1):22-8. PubMed ID: 17433492
[TBL] [Abstract][Full Text] [Related]
16. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.
Kim T; Oh PI; Simor AE
Infect Control Hosp Epidemiol; 2001 Feb; 22(2):99-104. PubMed ID: 11232886
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostics and Eradication Therapy for MRSA Carriers in the Outpatient Sector: an Analysis of the Reimbursement Situation in the Light of Current Reimbursement Changes].
Schwendler M; Hübner CS; Fleßa S
Gesundheitswesen; 2017 Oct; 79(10):855-862. PubMed ID: 27300096
[TBL] [Abstract][Full Text] [Related]
18. [Costs and benefits of an education program for patients with ankylosing spondylitis as part of an inpatient rehabilitation programs-study design and first results].
Krauth C; Rieger J; Bönisch A; Ehlebracht-König I
Z Rheumatol; 2003; 62(Suppl 2):II14-6. PubMed ID: 14648082
[TBL] [Abstract][Full Text] [Related]
19. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.
Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
Pharmacoeconomics; 2005; 23(4):377-93. PubMed ID: 15853437
[TBL] [Abstract][Full Text] [Related]
20. Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward.
Herr CE; Heckrodt TH; Hofmann FA; Schnettler R; Eikmann TF
Infect Control Hosp Epidemiol; 2003 Sep; 24(9):673-8. PubMed ID: 14510250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
